{"disease":{"id":"immune-thrombocytopenic-purpura-itp","name":"immune thrombocytopenic purpura itp"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06873672","title":"Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":360,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT00415532","title":"Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":234,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT06722235","title":"A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":171,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT06948318","title":"A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT03524612","title":"A Study to Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITP","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT01071954","title":"A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Patients With Immune (Idiopathic) Thrombocytopenia Purpura","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT00157079","title":"Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Baxalta now part of Shire","has_results":false},{"nct_id":"NCT03866577","title":"Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":50,"lead_sponsor_name":"Momenta Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT00162006","title":"Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Baxalta now part of Shire","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}